Atlas Trials

Checkpoint Inhibitors in Patients With Solid Tumors: a Retrospective Real-world Study

Clinical trial NCT05719324 · UNKNOWN

Trial details

NCT number
NCT05719324
Sponsor
The First Affiliated Hospital with Nanjing Medical University
Status
UNKNOWN
Study type
OBSERVATIONAL
Immunotherapy
Start date
2022-02-08
Primary completion
2023-03-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.